Omeros Balance Sheet
NASDAQ: OMERHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Omeros financial position
At the end of fiscal 2025, Omeros reported total assets of $325.6 million, up 17.5% from a year earlier against total liabilities of $446.9 million. Shareholders' equity was negative at -$121.2 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $9.7 million in cash and equivalents against $51.4 million of debt, a net debt position of $41.7 million.
The current ratio (current assets divided by current liabilities) was 2.76, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Omeros balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.66M | 3.40M | 7.11M | 11.01M | 100.81M | 10.50M | 3.08M | 5.86M | 3.39M | 2.22M |
| Short-Term Investments | 162.14M | 86.73M | 164.74M | 183.91M | 56.46M | 124.45M | 57.70M | 54.64M | — | — |
| Receivables | 0 | 7.74M | 8.10M | 213.22M | 38.16M | 3.84M | 35.19M | 22.82M | 17.14M | 12.04M |
| Inventory | 0 | — | — | — | — | 1.35M | 1.15M | 88.00K | 443.00K | 1.13M |
| Total Current Assets | 215.67M | 134.12M | 217.90M | 443.24M | 247.96M | 151.28M | 103.75M | 89.87M | 108.37M | 60.26M |
| Property, Plant & Equipment | 1.77M | 2.68M | 1.95M | 1.49M | 1.73M | 2.55M | 3.83M | 3.85M | 2.12M | 1.18M |
| Total Assets | 325.63M | 277.08M | 378.27M | 590.97M | 419.27M | 181.04M | 136.97M | 95.94M | 116.33M | 67.28M |
| Accounts Payable | 4.76M | 5.91M | 7.71M | 5.99M | 13.40M | 4.20M | 5.33M | 6.28M | 6.69M | 2.52M |
| Short-Term Debt | — | — | — | — | — | — | — | 889.00K | 490.00K | 198.00K |
| Total Current Liabilities | 78.06M | 79.53M | 53.32M | 136.38M | 51.79M | 36.74M | 55.46M | 37.36M | 26.31M | 16.07M |
| Long-Term Debt | 51.36M | 97.18M | 213.16M | 220.91M | 313.46M | 236.29M | 158.21M | 148.98M | 84.12M | 79.51M |
| Total Liabilities | 446.86M | 459.69M | 403.25M | 505.29M | 395.49M | 301.79M | 245.99M | 196.09M | 119.14M | 104.72M |
| Shareholders' Equity | -121.23M | -182.61M | -24.98M | 85.68M | 23.78M | -120.75M | -109.02M | -100.16M | -2.81M | -37.45M |
| Retained Earnings | -913.70M | -910.35M | -753.53M | -635.72M | -683.13M | -872.67M | -734.61M | -650.13M | -523.37M | -469.89M |
| Total Debt | 51.36M | 97.18M | 213.16M | 220.91M | 313.46M | 236.29M | 158.21M | 149.87M | 84.61M | 79.71M |
| Net Cash (Debt) | 120.44M | -7.05M | -41.31M | -25.99M | -156.19M | -101.33M | -97.42M | -89.37M | -81.21M | -77.49M |
| Shares Outstanding | 71.67M | 58.04M | 61.13M | 62.83M | 62.63M | 61.67M | 54.20M | 49.01M | 48.21M | 43.82M |
This table shows 10 annual periods of Omeros's balance sheet, from FY 2025 back to FY 2016, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow OMER's reporting calendar. What is a balance sheet?